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Platelet-rich fibrin (PRF) contains a broad spectrum of bioactive molecules that can trigger several 
cellular responses. However, these molecules along with their upstream responses remain mostly 
uninvestigated. By means of proteomics we revealed that PRF lysates contain more than 650 proteins, 
being TGF-β one of the few growth factors found. To uncover the major target genes regulated by 
PRF lysates, gingival fibroblasts were exposed to lysates obtained from PRF membranes followed by 
a whole genome array. We identified 51 genes strongly regulated by PRF including IL11, NOX4 and 
PRG4 which are characteristic TGF-β target genes. RT-PCR and immunoassay analysis confirmed the 
tGf-β receptor I kinase-dependent increased expression of IL11, NOX4 and PRG4. The PRF-derived 
tGf-β activity was verified by the translocation of Smad2/3 into the nucleus along with the increased 
phosphorylation of Smad3. Considering that PRF is clinically used in combination with dental implants 
and collagen membranes, we showed here that PRF-derived TGF-β activity adsorbs to titanium 
implants and collagen membranes indicated by the changes in gene expression and immunoassay 
analysis. Our study points towards TGF-β as major target of PRF and suggest that TGF-β activity 
released by PRF adsorbs to titanium surface and collagen membranes
Platelet-rich fibrin (PRF) has been proposed as an alternative approach to the application of recombinant growth 
factors to enhance wound healing and bone regeneration1. PRF is obtained by centrifugation and spontane-
ous coagulation of blood followed by the removal of the red corpuscle base2. The coagulated plasma contains 
a complex mixture of growth factors and other bioactive molecules enmeshed within a fibrin network3,4. This 
coagulated plasma can be further processed by squeezing out the serum, obtaining a PRF membrane. PRF mem-
branes have become an attractive strategy to maximize the clinical outcomes by delivering growth factors at the 
surgical site, either alone or in combination with dental implants and collagen membranes5,6. For example, PRF 
membranes can preserve the alveolar ridge dimension following tooth extraction7. Furthermore, dental implants 
coated with PRF increase their stability during the early phases of osseointegration5,8. Additionally, when PRF is 
combined with a collagen membrane in a guided bone regeneration approach it can preserve the alveolar ridge 
profile9. However, and despite these promising clinical results, the underlying cellular and molecular mechanisms 
induced by PRF are poorly understood10.
Mesenchymal lineage cells are among the possible targets at sites where PRF is applied. In the oral cavity, mes-
enchymal cells are found in the gingiva11. Consequently, it is not surprising that gingival fibroblasts are common 
targets for assessment of cell responses. For example, cell proliferation or osteogenic differentiation in response 
to PRF can be measured via changes in gene expression12,13. This screening approach can be further refined by 
means of whole genome arrays. Gene arrays are comprehensive analytical tools and have been used to screen 
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target genes that are regulated in monocytes in response to platelet-derived microvesicles14. Hence, the first aim 
of this study was to identify clusters of cellular responses that may help to find the upstream signalling pathways 
triggered by PRF since the genetic signature in oral fibroblasts exposed to PRF lysates has not yet been identified.
PRF lysates encompassing growth factors and other bioactive molecules that are released at the surgical 
site can be prepared by the freeze-thawing of PRF membranes15. Immunoassays have identified characteristic 
platelet-released molecules including TGF-β in PRF lysates16 and PRF-conditioned medium17. While advanced 
proteomic technology has been steadily refined to elucidate the protein composition of purified platelets18, this 
approach has not been utilized in characterizing the protein signature of PRF membranes. Thus, the relevance of 
proteomics technology is to extend current knowledge of growth factors and other proteins that may cause a potent 
cellular response. The second aim of the present study was to combine the proteomic approach with the findings 
from the gene array to understand which PRF-derived growth factors cause the major changes in gene expression.
PRF-derived growth factors such as TGF-β have been identified to adsorb to biomaterials including tita-
nium19,20 and collagen membranes21,22. The biological role of this binding nevertheless remains to be elucidated. 
Thus, and since PRF is frequently combined with the aforementioned biomaterials, the question arises whether 
PRF-derived growth factors that cause the major changes in gene expression – adsorb to these biomaterials. We 
have therefore included a series of experiments, similar to our previous research with acid bone lysates20,23. In 
order to mimic a clinical situation in an in vitro setting, we examined whether the growth factors released by PRF 
activates mesenchymal cells bound to the respective biomaterials. This is clinically relevant as local application of 
recombinant TGF-β in a collagen sponge can enhance bone regeneration of rabbit skull defects24. Thus, the final 
aim of this research was to investigate if the growth factors, which cause the most robust gene expression changes, 
adsorb to titanium and collagen membranes.
In the present study we show that (i) TGF-β is found in PRF lysates based on proteomic analysis; (ii) PRF 
lysates provoke a robust activation of TGF-β signalling in oral gingival fibroblasts based on genomic screening 
and a series of specific downstream analysis; (iii) PRF-derived TGF-β activity adsorbs to titanium implants and 
collagen membranes.
Results
Proteomics analysis of PRF lysates. To understand the composition of the PRF lysates, a proteomic 
analysis was performed. Mass spectrometry revealed 652 proteins (Supplement Table 1). Interestingly, only a few 
classical growth factors were detected including TGF-β, hepatoma-derived growth factor (HDGF), and mye-
loid-derived growth factor (MYDGF). Identified were also the latent-TGF-β-binding protein 1 (LTBP1), hepat-
ocyte growth factor activator (HGFAC), hepatocyte growth factor-like protein (MST1), epidermal growth factor 
receptor substrate 15 (EPS15), insulin-like growth factor-binding protein complex acid labile subunit (IGFALS). 
We could also confirm the presence of typical platelets proteins, such as platelet factor 4 (PF4), platelet basic pro-
tein (PPBP), platelets glycoproteins (GP1BA, GP1BB CD36, GP5, GP6, GP9), platelet endothelial cell adhesion 
molecule (PECAM1), and von Willebrand factor (VWF).
Gene Ontology (GO) Enrichment Analysis of PRF lysates included biological process, molecular function, 
cellular component, KEGG (Kyoto Encyclopedia of Genes and Genomes) and Reactome. For example, Reactome 
enriched HSA-168249 (Innate Immune System), HSA-168256 (Immune System), HSA-109582 (Hemostasis), 
HSA-6798695 (Neutrophil degranulation), HSA-76002 (Platelet activation, signaling and aggregation) and HSA-
114608 (Platelet degranulation). Top ranked in KEPP were hsa04610 (Complement and coagulation cascades) 
and hsa04611 (Platelet activation). Overall, the GO analysis of PRF lysates identified the expected activation of 
platelets and neutrophils but not explicitly the TGF-β-related enrichments. Thus, the question arises; What is the 
cellular response of gingival fibroblasts exposed to PRF lysates?
Genomic profiling triggered by PRF lysates. To gain insights into the major response of gingival fibro-
blasts to PRF lysates, we analyzed the gene expression profile by genomics. To this end, gingival fibroblasts were 
either treated with PRF lysates for 24 hours or left untreated. The data revealed a total of 51 genes that were dif-
ferentially expressed with at least 5-fold change. Among these genes, 28 were up-regulated (Table 1) and 23 were 
down-regulated (Table 2). A basic Gene Ontology Enrichment Analysis of genes regulated by PRF lysates was 
performed. For example, Molecular Function highlights GO:0005125 (cytokine activity), and Biological Processes 
that are activated are enriched for GO:0019221 (cytokine-mediated signaling pathway) and GO:0050896 
(response to stimulus). Reactome highlights HSA-1280215 (Cytokine Signalling in Immune system) and HSA-
913531 (Interferon Signaling). There was no explicit enrichment for NOX4, IL11, and PRG4. Nevertheless, NOX4 
was the most strongly regulated gene by PRF lysates (Table 1) and consistent with our previous research on TGF-β 
signalling23,25,26, IL11 and PRG4 were also identified (Table 1). Thus, and based on our previous experience with 
enamel matrix derivative25, bone conditioned medium26 and acid bone lysates23, this triad of genes was selected 
to measure the response of fibroblasts to TGF-β activity.
pRf activates tGf-β signalling in human fibroblasts. To determine the most suitable concentration 
to produce significant changes on mRNA transcripts and proteins, gingival fibroblasts were exposed to differ-
ent concentrations of PRF lysates. PRF acted in a dose-dependent manner showing that 30% of PRF was suffi-
cient to induce a considerable increase of IL11, NOX4, and PRG4 (Fig. 1A). In line with mRNA transcripts, the 
dose-dependent activity was validated by IL11 immunoassay (Fig. 1B). These results indicate that 30% of PRF 
lysates can provoke a robust expression of IL11, NOX4, and PRG4 in gingival fibroblasts.
Considering the presence of TGF-β in PRF lysates and the robust up-regulation induced, we then sought 
to confirm whether TGF-β signalling mediates the up-regulation of the selected genes. To this end, the TGF-β 
receptor I kinase antagonist SB431542 and TGF-β receptor kinase inhibitor LY2157299 were utilized. Notably, 
SB431542 inhibited the up-regulation of all target genes (Fig. 2A). This inhibition was also confirmed with 
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LY2157299, obtaining similar results (Fig. 2B). Moreover, SB431542 blocked the IL11 production on the protein 
level (Fig. 2B). As the canonical TGF-β activity acts via Smad proteins, we examined whether PRF triggers the 
nuclear translocation and the phosphorylation of smad3. Immunofluorescence analysis revealed that PRF pro-
motes the nuclear translocation of Smad2/3 in gingival fibroblasts (Fig. 2C). Western blot analysis confirmed 
phosphorylation of smad3 by PRF (Fig. 2D). Taken together these findings indicate that IL11, NOX4, and PRG4 
are the major triggers of PRF-derived TGF-β in gingival fibroblasts.
Titanium surface and collagen membrane absorbs the PRF-derived TGF-β activity. Since 
PRF has been widely used during implant placement to boost osseointegration5 we examined first whether the 
PRF-activity absorbs to titanium surfaces. Gingival fibroblasts were seeded onto titanium discs as previously 
described20. Titanium surfaces exposed to PRF followed by vigorous washings with buffered saline caused a 
robust gene expression of IL11, NOX4, and PRG4 in gingival fibroblasts (Fig. 3A). As anticipated, SB431542 
blocked the differential expression of the mRNA transcripts. To further verify this activity at the protein level, 
IL11 immunoassay was performed. PRF induced the release of IL11 into the supernatant of gingival fibroblasts 
and the presence of SB431542 significantly reduced its release (Fig. 3B).
PRF membranes have been increasingly applied in guided bone regeneration together with the standard col-
lagen membrane to enhance bone regeneration27. As collagen can efficiently adsorb TGF-β28 we examined next 
whether the PRF-derived TGF-β activity absorbs to collagen membranes. Collagen membranes were exposed 
to PRF followed by vigorous washing with buffered saline. Then, gingival fibroblasts were seeded onto colla-
gen membranes. Collagen absorbed the TGF-β activity of PRF lysates indicated by the differential expression of 
mRNA transcripts IL11, NOX4 and PRG4 (Fig. 3C) – and particularly by the strong increase of IL11 release into 
the supernatant (Fig. 3D). Altogether, these observations indicate that PRF-derived TGF-β activity absorbs to 
biomaterials such as titanium and collagen membranes.
pRf-derived tGf-β activity is preserved at drilling temperatures. PRF is commonly utilized as a 
coating agent for dental implants. Considering that during the drilling of the bone the temperature could increase 
above 47 °C29 and latent TGF-β can be thermally activated but also denaturated at high temperatures, we exam-
ined whether the temperature had an impact on the PRF activity. To this end, PRF extracts were heated either to 
56° or 95°. Then, gingival fibroblasts were stimulated with heated or unheated PRF. The heat-treatment of PRF at 
56 °C for five minutes did not affect the expression of the target genes relative to control PRF at room temperature 
Gene Symbol Fold Change
NOX4 12.1
MCM10 10.2
TSPAN13 9.7
FAM111B 9.0
ANGPTL4 8.6
MT1L 8.6
KCNN4 8.6
IL33 8.1
UHRF1 7.4
HIST1H3F 7.3
CLSPN 7.1
PSAT1 7.1
EXO1 6.5
PSAT1 6.3
PLEK2 6.1
IL13RA2 6.1
ID1 6.0
ZNF367 5.8
PRG4 5.7
TCF19 5.4
GPAM 5.4
C4orf26 5.4
GPR183 5.4
ASNS 5.4
IL11 5.3
HIST1H3I 5.3
SERPINE1 5.2
L2DTL 5.1
Table 1. Up-regulated genes with at least 5x changes in oral fibroblasts exposed to PRF lysates. Gingival 
fibroblasts were treated with and without PRF lysates for 24 hours and a differential analysis was carried out.
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(Fig. 4A). The heat-treatment of PRF at 95 °C for five minutes, however, abolished the TGF-β activity (Fig. 4A). 
These results were verified at the protein level via IL11 immunoassay (Fig. 4B). Our observations suggest that 
PRF-derived TGF-β activity is not affected significantly by the surgical procedure itself.
PRF lysates reduce osteoblast differentiation in calvaria-derived osteoblasts. Apart from the triade 
of target genes identified, we performed an initial experiment to evaluate the impact of PRF lysates on osteogenic dif-
ferentiation, a process that is essential for bone formation. We selected the widely used calvaria cells isolated from neo-
natal mice as a resource for osteogenic cells for in vitro assays30. Considering that recombinant TGF-β reduces alkaline 
phosphatase activity of murine calvaria-derived osteoblasts31, and that alkaline phosphatase is an early indicator of 
osteogenic differentiation32, we examined the effect of PRF lysates on the alkaline phosphatase activity on murine 
calvaria-derived osteoblasts. Notably, PRF reduced alkaline phosphatase activity as compared to the control group 
(Fig. 5A). This reduction was further verified by combining PRF with BMP2. These observations were corroborated 
at the gene expression level (Fig. 5B). Altogether, these findings further support the TGF-β activity of PRF lysates.
Discussion
This is the first study on PRF that integrates robust and comprehensive analytical tools thereby providing insights 
into the cellular and molecular mechanisms triggered by PRF. One major finding was that among the 652 pro-
teins identified in lysates of PRF membranes, TGF-β was one of the few growth factors found. Consistently, gene 
array revealed three TGF-β target genes namely IL11, NOX4, and PRG4 among the 51 strongly regulated genes 
Gene Symbol Fold Change
IFI44L 0.09
MX1 0.09
CXCL10 0.09
MX2 0.10
OAS1 0.10
XAF1 0.13
SLC7A14 0.14
HERC5 0.15
LOC728613 0.15
DIRAS3 0.16
TSPAN2 0.17
LOC284412 0.18
TRABD2B 0.18
RORB 0.18
IL34 0.18
CYP7B1 0.18
HERC6 0.19
ADAMTS9-AS2 0.19
VCAM1 0.19
TNFSF13B 0.19
TGFB3 0.19
ALDH3A1 0.19
SLC39A8 0.19
Table 2. Down-regulated genes with at least 5x changes in oral fibroblasts exposed to PRF lysates. Gingival 
fibroblasts were treated with and without PRF lysates for 24 hours and a differential analysis was carried out.
Figure 1. PRF effect is dose-dependent. Gingival fibroblasts were incubated with various concentrations of 
soluble extracts of PRF. (A) Reverse transcription PCR analysis for IL11, NOX4 and PRG4. (B) Quantification 
of IL11 in the supernatant by immunoassay. N = 3–4. Data are presented as mean ± SD.
5Scientific RepoRtS |        (2020) 10:10203  | https://doi.org/10.1038/s41598-020-67167-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
by PRF lysates. Apart from inducing a robust TGF-β response in fibroblasts, these three target genes mediate 
downstream effects of TGF-β and play a role in bone homeostasis. For example, PRG4 regulates the maturation of 
the subchondral bone and holds an anti-inflammatory activity in synovial fibroblasts33. IL11 induces bone regen-
eration34 and acts synergistically with BMP-2 to enhance bone formation35. IL11 produced by fibroblasts is the 
dominant transcriptional response to TGFβ1 exposure and vital for its pro-fibrotic effect in vivo36. Lastly, NOX4 
is related to the activation of bone-resorbing osteoclasts37 and also mediates the TGFβ1-driven myofibroblasts 
differentiation in lung fibrosis38. Therefore, our findings also raise the possibility that IL11 and NOX4, in response 
to PRF lysates, may induce a pro-fibrotic differentiation in fibroblasts.
If we relate the current findings to those described by others, our proteomics approach confirms the work 
based on traditional immunoassays showing the release of TGF-β among other growth factors from PRF mem-
branes3,17. These results mirror those observed with previous preparations with leucocyte-depleted platelets sub-
jected to proteomic analysis18,39. Our research strategy is in line with gene array approaches to identify major 
target genes, for example in gingival fibroblasts exposed to enamel matrix derivative25, acid bone lysates23, and 
PRP gene arrays in a mouse model of mandibular advancement40. It is thus not surprising that the TGF-β activ-
ity of PRF lysates is a major pathway indicated by the robust up-regulation of IL11, NOX4 and PRG4. This was 
confirmed by using two independent TGF-β receptor kinase inhibitors thereby blocking the expression of IL11, 
NOX4 and PRG4. The activation of the Smad2/3 canonical signalling pathway by PRF corroborated our findings, 
which are in line with previous research on bone-derived TGF-β20,23. However, it is unlikely that TGF-β is the 
only growth factor in PRF lysates capable of inducing a cellular response. Indeed, the platelet lipidome comprises 
almost 400 lipid species41 such as the potent sphingosine-1-phosphate affecting bone turnover42 which are not 
covered by the proteomic analysis.
The fact that other classical growth factors such as PDGF isoforms, VEGF and or IGF117 were not identified 
by proteomic analysis does not fully discard their presence in the sample since they might be below the limit of 
detection or simply render few detectable peptides. Growth factors and cytokines are usually found in low con-
centrations in biological samples but, even in such low concentrations, they are able to display their functions. We 
also identified HDGF that plays a pro-fibrogenic role during liver fibrosis in mice through activation of TGF-β 
pathway43 and MYDGF that helps to protect and repair the heart after acute myocardial infarction44. We fur-
ther found PF4, also known as chemokine ligand 4 (CXCL4), which is released from alpha-granules of activated 
platelets45. Nonetheless, the impact of HDGF, MYDGF and PF4 on gene expression changes in oral fibroblasts 
remains to be investigated. As a consequence, we mainly focused on the three strongly regulated genes that we 
have previously identified to be sensitive to TGF-β signalling23,25,26. Further research should therefore identify 
the other signaling pathways that lead to the differentially gene expression in response to PRF lysates. We are 
currently preparing a genomic analysis similar to our previous approach on enamel matrix derivatives25 with 
Figure 2. PRF activates TGF-β signalling in human fibroblasts. Gingival fibroblasts were stimulated with 
soluble PRF lysates in the absence or presence of the TGF- β receptor I kinase antagonist SB431542 or TGF- β 
receptor I inhibitor galunisertib LY2157299. (A) Reverse transcription PCR analysis for IL11, NOX4 and PRG4 
with or without SB431542. (B) Reverse transcription PCR analysis for IL11, NOX4 and PRG4 with or without 
LY2157299. (C) Quantification of IL11 levels by immunoassay. (D) Representative immunofluorescence of the 
translocation of Smad2/3 into the nucleus upon stimulation with PRF and recombinant TGF-β, w/o; without. 
(E) Incubation of gingival fibroblasts with PRF increased phosphorylation of Smad3, treatment with 10 ng/ml 
of TGF-β was used as a positive control, full-length blots are presented in supplementary figure 2. N = 4–6. Data 
represent the mean ± SD, *P < 0.05, **P < 0.01, ***P < 0.001, by two-tailed Mann-Whitney test.
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and without the presence of the TGF-β receptor I kinase antagonist SB431542 in order to differentiate the genes 
targeted by TGF-β and those regulated independently this signaling pathway.
To gain further insights into the biological effect of PRF, we investigated the osteoblastic differentiation based 
on alkaline phosphatase histochemical staining and gene expression analysis in calvaria cells. Alkaline phos-
phatase activity is an early osteoblast differentiation marker32. We found here that PRF lysates attenuated the 
alkaline phosphatase activity. PRF lysates could even reduce the BMP2-induced up-regulation of the alkaline 
phosphatase. These observations are in alignment with a previous study on periodontal ligament fibroblasts46 
and might be attributed to the PRF-derived TGF-β activity thereby reducing the alkaline phosphatase activity on 
calvaria-derived osteoblasts31. The role of TGF-β signalling to mediate the effects of PRF lysates on osteogenic 
Figure 3. PRF-derived TGF-β activity absorbs to titanium surface and collagen membrane. Titanium discs were 
treated with PRF for 1 hour followed by three vigorous washes with buffered saline. Then, Gingival fibroblasts 
were seeded onto the PRF coated titanium discs overnight with and without the inhibitor for the TGF-β RI 
kinase SB431542. (A) Reverse transcription PCR analysis for IL11, NOX4 and PRG4. (B) Quantification of 
IL11 levels by immunoassay. Collagen membranes were treated with PRF lysates for 1 hour followed by three 
vigorous washes with buffered saline. Then, gingival fibroblasts were seeded onto the PRF-coated collagen 
membranes overnight. (C) Reverse transcription PCR analysis for IL11, NOX4 and PRG4. (D) Quantification 
of IL11 levels by immunoassay. N = 4–6. Data represent the mean ± SD, *P < 0.05, **P < 0.01, by two-tailed 
Mann-Whitney test.
Figure 4. PRF loses its TGF-β activity at high temperatures. PRF lysates were heated either at 56° or 95°. Then, 
gingival fibroblasts were stimulated with unheated (RT) or heated PRF. (A) Reverse transcription PCR analysis 
for IL11, NOX4 and PRG4 using unheated or heated PRF. (B) Quantification of IL11 levels by immunoassay. 
w/o; without. N = 4–6. Data represent the mean ± SD, *P < 0.05, by two-tailed Mann-Whitney test.
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differentiation and bone formation, however, remains to be determined. In contrast, other studies have found an 
enhancement of alkaline phosphatase by PRF in many cell types47, including human bone cells13, mesenchymal 
cells12 and pulp cells48. These conflicting results might be explained to some extent by the methodological dis-
crepancies and the different cell types. The majority of the aforementioned reports used different protocols and 
centrifuges to produce PRF17.
Although the clinical relevance of our discoveries is a matter of speculation, they might have an impact 
on guided bone regeneration (GBR) and implant dentistry. GBR is a common biomaterial-based and 
well-documented clinical procedure that aims at the regeneration of hard tissues either in alveolar bone defects 
or in peri-implant defects49. GBR is based on the principle of using a barrier membrane with a bone graft under-
neath. Recently, this procedure has been combined with PRF in order to maximize the clinical outcomes9. Even 
though the incorporation of growth factors into collagen membrane is not novel we are the first to show that 
PRF-derived TGF-β activity adsorbs to collagen membrane and resists vigorous washings. The present findings 
were not unexpected since TGF-β, BMP2 and other growth factors can adsorb to collagen21,22 and are com-
bined for better growth factor binding and release. Furthermore, we showed that PRF-derived TGF-β activity 
also adsorbs to titanium surfaces. This accords with our earlier observations, which showed that the bone-derived 
TGF-β activity binds to titanium surfaces20. Considering that PRF increases implant stability of dental implants at 
early stages5,8, PRF-derived TGF-β activity may play a critical role in the early phases of osseointegration20. In this 
sense, a sustained delivery of growth factors by functionalized biomaterials, particular collagen membranes and 
dental implants, might be advantageous for bone regeneration and wound healing, nonetheless future research is 
necessary to confirm this hypothesis.
The present study has a number of limitations. First, considering the debates on the impact of g-forces and 
the selection of tubes on the composition of PRF50, we only applied  one protocol, using 400 g calculated at 
RCF-max to prepare PRF membranes. Second, the screening for target genes is based on a selection of three 
highly expressed genes that were identified downstream upon TGF-β receptor activation mainly based on our 
previous research with enamel matrix derivative25, acid bone lysates23, and bone conditioned medium26. Hence, 
other genes that are also responsive to PRF playing a possible role in vivo might have been neglected. Third, gin-
gival fibroblasts where not characterized and after a few passages the cells may change their expression pattern 
demanding further characterization. However, our data are rather consistent with previous reports. Furthermore, 
gingival fibroblasts represent one out of many possible target cells for PRF and it is likely that the beneficial effect 
of PRF in vivo requires the crosstalk between multiple cell types. The robust TGF-β activation might only be rel-
evant for mesenchymal cells while other cell types require the activation by other cues apart from growth factors. 
Finally, even though we have identified the adsorption of the TGF-β activity to titanium and collagen membranes, 
and both biomaterials are routinely used for oral regeneration8,27,51, the clinical implication of these findings 
remains unclear but inspires future research.
Future research should therefore focus on other cell types to further evaluate the potential of tissue-targeted 
PRF. Moreover, owing to the diversity of PRF protocols across the disciplines, further research is necessary for 
detailed constituents of different PRF preparations. It remains unclear whether TGF-β plays a pivotal role in all 
the different preparations. Our study provides, however, a valuable PRF dataset for future comparisons especially 
in terms of protein expression profiles. The interaction and combination of different biomaterials with PRF will 
Figure 5. PRF lysates attenuate osteoblast differentiation in calvaria-derived osteoblasts. (A) Qualitative 
visualization of alkaline phosphatase staining in calvaria-derived osteoblasts. Scale bar is 500 μm. (B) Reverse 
transcription PCR analysis for ALP in the absence or presence of BMP2. BMP2 was used as a positive control. 
N = 4. Data represent the mean ± SD, *P < 0.05, by two-tailed Mann-Whitney test.
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require tight control and understanding of the host system to ensure cell engraftment and tissue responsiveness. 
The most suitable combination to program cell fate resulting in predictable therapeutic outcomes, still remains to 
be elucidated. There is a clinical need for predictable therapeutic strategies that can translate into everyday use, 
not only in clinical dental practice but also across other medical specialties. In this sense, PRF offers us a unique 
opportunity in clinical translational research since autologous preparations of growth factors from blood usually 
need no formal approval thereby accelerating the translation of this therapy.
Conclusion
In summary, the present study revealed that the expression of the TGFβ target genes IL11, NOX4 and PRG4 on 
gingival fibroblasts is a dominant transcriptional response to PRF.
Material and Methods
Preparation of PRF lysates and conditioned medium. PRF membranes were obtained and prepared 
following a standard protocol previously reported52,53. After the approval by the ethics committee of the Medical 
University of Vienna (1644/2018), venous blood was collected at the University Clinic of Dentistry from six 
healthy volunteers. Before drawing the blood, each volunteer was required to sign an informed consent to partic-
ipate in the study. Then, each volunteer donated six plastic glass-coated tubes (BD Vacutainer® Ref 367896; BD, 
Plymouth, UK) allowing spontaneous blood coagulation. Platelet Rich Fibrin (PRF) clots were produced utilizing 
a protocol of 1570 RPM for 12 minutes (RCF-max = 400 g). PRF membranes were produced utilizing a centrifuge 
device (Z 306 Hermle Universal Centrifuge, Wehingen, Germany) with universal swing-out rotors (146 mm at 
the max) utilizing 10 mL glass-coated plastic tubes. The PRF clot was separated from the remaining red thrombus 
and compressed between two layers of dry gauze. Each PRF membrane is transferred into serum-free medium 
(1 cm PRF/ml) and exposed to two cycles of freeze-thawing and sonication (Sonopuls 2000.2, Bandelin elec-
tronic, Berlin, Germany) as reported for human platelet lysate15,54,55. After centrifugation (Eppendorf AG-22331, 
centrifuge 5424, Hamburg, Germany) at 15000 g for 10 minutes, the supernatants of the PRF membranes were 
harvested and stored at −20 °C prior to the in vitro analysis. In indicated experiments, PRF membranes were 
transferred into serum-free medium (1 cm PRF/ml) and placed into an incubator at 37 °C to allow a natural 
release of growth factors into the culture media, similarly as previously described17. At 24 hours the conditioned 
medium was collected. All experiments were performed in accordance with relevant guidelines and regulations.
Cell culture. Tissue samples of human gingiva were harvested from extracted third molars from patients 
who had given informed and written consent. Before obtaining the samples, the Ethics Committee of the Medical 
University of Vienna (EK NR 631/2007) approved the protocol. A total of three strains of fibroblasts were estab-
lished by explant cultures and fewer than 10 passages were used for the experiments. Calvaria-derived osteoblasts 
were obtained according to a standard protocol previously described (Oishi et al. 2016). Briefly, mouse pups less 
than 5 days old were euthanized and their calvaria collagenase digested through a series of sequential digestions. 
The first 2 digests were discarded, and the subsequent digests were pooled and plated. Cells were seeded at a con-
centration of 30,000 cells/cm² onto culture dishes one day prior to stimulation. Cells were also treated overnight 
with and without different concentrations of PRF lysates up to 30% in serum-free media before gene expression 
was analyzed. Alternatively, cells were stimulated with heated PRF at 56 °C or 95 °C. In indicated experiments, 
cells were exposed to PRF conditioned medium instead of PRF lysates. Additionally, machined titanium discs 
(Ti Gr. 4; Implacil De Bortoli, São Paulo, Brazil) and collagen membranes (Bio Guide®, Geistlich Biomaterials, 
Wolhusen, Switzerland) were immersed in PRF for one hour at room temperature, followed by three washings 
with phosphate buffer saline as previously described20. To examine the influence of TGF-β signaling, the inhibitor 
of TGF-β receptor type I kinase, SB431542 (Calbiochem, Merck, Billerica, MA) was used at 10 µM.
Cell differentiation. As stated recently23, for osteogenic differentiation, calvaria cells were incubated in 
growth medium containing 50 μg/mL ascorbic acid (Sigma Aldrich, St. Louis, MO) and 10 mM beta glycerophos-
phate (Sigma Aldrich, St. Louis, MO) as previously reported23. Alkaline phosphatase staining was performed after 
3 day. For histochemical staining of alkaline phosphatase, cells were fixed as indicated and incubated with a sub-
strate solution containing naphthol AS-TR phosphate and fast blue BB salt (Sigma Aldrich, St. Louis, MO)56. After 
rinsing with distilled water, cultures were photographed. Slides were imaged using an Oxion Inverso microscope 
(Euromex, Arnhem, The Netherlands) with a 4× objective.
Proteomic analysis. The detailed protocol is presented in the supplement and was recently reported23. PRF 
lysates from a pool of three independent donors were subjected to proteomic analysis. In brief, PRF lysates were 
dissolved in 1% Rapigest in 50 mM TEAB and the solution was filtered through a molecular-weight cut-off filter 
of 100 kDa first. The resulting filtrate was then passed through a 50 kDa filter and four fractions were gener-
ated – two filtrates and two concentrates. Extracted proteins were reconstituted from the membrane and from 
the filtrate, precipitated using methanol/dichloromethane and digested with trypsin as described earlier57. In 
total four fractions were generated and analyzed. Protein concentration was determined using the DeNovix 
DS-11 FX Spectrophotometer (Wilmington, USA) and proteins were reduced using 5 mM DTT (Dithiothreitol, 
Sigma-Aldrich, Vienna, Austria) for 30 minutes at 60 °C, and alkylated for 30 minutes with 15 mM IAA 
(Iodoacetamide, Sigma-Aldrich, Vienna, Austria) in the dark. Finally, porcine trypsin (Promega, Vienna, Austria) 
was added in a ratio trypsin to protein 1:50 (w/w). After 16 hours of incubation at 37 °C, aliquots of 20 µl were 
prepared and stored in 0.5 ml protein low-bind vials (Eppendorf, Vienna, Austria) at −20 °C until injection on 
next day. The nano HPLC separation of each fraction was performed using a nanoRSLC UltiMate 3000 HPLC sys-
tem by Thermo Fisher. Raw MS/MS files were analyzed using Proteome Discoverer 2.2 (ThermoFisher Scientific, 
Bremen, Germany) and searching the Swissprot database (Homo sapiens, http://www.uniprot.org/proteomes/
UP000009606, version from May 2019). Search parameters are presented in the Supplement material. All search 
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results were refined and researched using Scaffold 4.6.5 (Proteome Software, Portland, OR). For the classifica-
tion of the proteins the STRING online software was applied (https://string-db.org)58. The mass spectrometry 
proteomics data have been deposited to the ProteomeXchange Consortium (www.proteomexchange.org) via the 
PRIDE partner repository (www.ebi.ac.uk/pride) with the dataset identifier PXD014382 and 10.6019/PXD014382.
Microarray analysis. Microarray analysis was carried out as previously described23. Total RNA from gingival 
fibroblasts exposed to 30% PRF lysates or left untreated was harvested with the RNA Isolation Kit (Extractme, 
BLIRT S.A., Gdańsk, Poland). RNA quality was determined using the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA, USA). Microarray analysis was performed using the SurePrint G3 Human Gene 
Expression v2 Microarray (Agilent Technologies, Santa Clara, CA). Array image acquisition was performed with the 
Agilent G2505B Microarray Scanner and Feature Extraction software version 9.5 (Agilent). Background-corrected 
fluorescence intensity values were imported into GeneSpring v.15, log2-transformed, and then normalized by quan-
tile normalization. A filtering step was applied in order to reduce the number of multiple hypotheses. Only genes for 
which at least 100% of the values in one of the two evaluated conditions were above the 60th percentile were used 
for further analysis. Differentially expressed mRNAs were identified by paired t-tests in GeneSpring. The resulting 
p-values were corrected for multiplicity by applying Benjamini-Hochberg adjustment to all p-values calculated for 
a time point with a false discovery rate (FDR)  <  5%59. Genes with an adjusted p-value <0.05 were considered sig-
nificant. Shown are genes that are at least 5-fold changed compared to an unstimulated control.
RT-PCR and immunoassay. Comparable to our previous research23, total RNA was isolated with the 
ExtractMe total RNA kit (Blirt S.A., Gdańsk, Poland). Reverse transcription (RT) was performed with the 
SensiFAST™ cDNA Synthesis Kit (Bioline Reagents Ltd., London, UK). RT-PCR was done with SensiFAST™ 
SYBR® Kit using manufacturer’s instructions (Bioline). Amplification was performed with the Biorad CFX 
Connect Real-Time PCR System (CFX Connect, BioRad, Hercules, CA, USA). Primer sequences are given in 
Table 3 except for IL11 which was purchased from BioRad (Hercules, CA, USA). Relative gene expression was 
calculated with the delta delta CT method using the analysis CFX Maestro™ software (BioRad, Hercules, CA, 
USA). Reactions were run in duplicates. The supernatant was analyzed for IL11 by immunoassay according to the 
manufacture’s instruction (R&D Systems, Minneapolis, MN, USA).
Western blot. Western blot was conducted as reported23. In brief, cell extracts containing SDS buffer and 
protease inhibitors (PhosSTOP with cOmplete; Sigma, St. Louis, MO) were separated by SDS-PAGE and trans-
ferred onto PVDF membranes (Roche Diagnostics, Mannheim, Germany). Membranes were blocked and incu-
bated with the first antibody (rabbit anti-pSmad3 Ser423/425, 1:500, Abcam, ab52903, Cambridge, UK) and actin 
(Santa Cruz Biotechnology, SCBT, Santa Cruz, CA, USA) overnight. The primary antibodies were then detected 
using the appropriate secondary antibody. Subsequently, chemiluminescence detection was performed with a 
ChemiDoc MP System (Bio‐Rad Laboratories, Inc. CA, USA).
Immunofluorescence. Immunofluorescent analysis was performed as recently described23. Briefly, human 
gingival fibroblasts were plated onto Millicell® EZ slides (Merck KGaA, Darmstadt, Germany) and treated with PRF 
30% for 30 min. Cells were then fixed in paraformaldehyde and blocked in 5% BSA and 0.3% Triton in PBS at room 
temperature for 1 hour. Cells were subsequently incubated with Smad2/3 antibody (1:800; D7G7 XP® Rabbit mAb 
#8685, Cell Signaling, MA, USA) overnight at 4 °C. Alexa Fluor 488 secondary antibody (1:1000; Anti-Rabbit, Cell 
signaling Technology, USA) was applied for 1 hour. Cells were washed and mounted onto glass slides. Fluorescent 
images were captured at 10x and 100x in oil immersion using a Zeiss Axiovert 200 M fluorescent microscope.
Statistical analysis. The experiments were repeated three to five times. Bars show the mean and standard 
deviation of the cumulative data from all experiments. The Shapiro–Wilk test was used to test the normality 
of the data sets. Statistical analysis was based on Mann-Whitney U test and Kruskal-Wallis test with Dunn’s 
multiple comparisons correction. Analyses were performed using Prism v7 (GraphPad Software, La Jolla, CA). 
Significance was set at p < 0.05.
Data availability
The raw required to reproduce the findings from this study will be made available to interested investigators upon 
request.
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Sequence_F Sequence_R
hPRG4 cag ttg cag gtg gca tct c tcg tga ttc agc aag ttt cat c
hNOX4 tct tgg ctt acc tcc gag ga ctc ctg gtt ctc ctg ctt gg
hGAPDH aag cca cat cgc tca gac ac gcc caa tac gac caa atc c
mALP aac cca gac aca agc att cc gag aca ttt tcc cgt tca cc
mbactin cta agg cca acc gtg aaa ag acc aga ggc ata cag gga ca
mGAPDH aac ttt ggc att gtg gaa gg gga tgc agg gat gat gtt ct
Table 3. Primer list.
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